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Abstract
Background: Current guidelines recommend education, physical activity and changes in diet for
type 2 diabetes patients, yet the composition and organization of non-pharmacological care are still
controversial. Therefore, it is very important that programmes aiming to improve non-
pharmacological treatment of type 2 diabetes are developed and evaluated. The Copenhagen Type
2 Diabetes Rehabilitation Project aims to evaluate the effectiveness of a new group-based lifestyle
rehabilitation programme in a Health Care Centre in primary care.
Methods/Design:  The group-based diabetes rehabilitation programme consists of
empowerment-based education, supervised exercise and dietary intervention. The effectiveness of
this multi-disciplinary intervention is compared with conventional individual counselling in a
Diabetes Outpatient Clinic and evaluated in a prospective and randomized controlled trial. During
the recruitment period of 18 months 180 type 2 diabetes patients will be randomized to the
intervention group and the control group. Effects on glycaemic control, quality of life, self-rated
diabetes symptoms, body composition, blood pressure, lipids, insulin resistance, beta-cell function
and physical fitness will be examined after 6, 12 and 24 months.
Discussion: The Copenhagen Type 2 Diabetes Rehabilitation Project evaluates a multi-disciplinary
non-pharmacological intervention programme in a primary care setting and provides important
information about how to organize non-pharmacological care for type 2 diabetes patients.
Trail Registration: ClinicalTrials.gov registration number: NCT00284609.
Background
Type 2 diabetes mellitus (T2DM) is a chronic disease with
severe late complications and high mortality. The increas-
ing prevalence of T2DM is mainly due to reduced physical
activity and consumption of unhealthy food and larger
portion sizes in genetic susceptible individuals. Lifestyle
intervention can prevent development of T2DM in sub-
jects with impaired glucose tolerance [1,2]. To improve
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metabolism and reduce the risk of late complications of
T2DM, permanent changes in lifestyle and lifelong multi-
pharmacological treatment are needed [3].
Group-based lifestyle intervention programmes for T2DM
patients, including patient education or supervised exer-
cise, have been evaluated in several randomized control-
led trials. Education programmes alone improves
glycaemic control in some studies [4,5], but not in all [6].
Group-based diabetes education seems to have a better
effect on glycaemic control than individual education [7-
10]. However the studies and interventions included in
these meta-analyses are very heterogeneous.
Isolated aerobic exercise [11], resistance training [12], and
the combination of these[13] resulted in better glycaemic
outcomes compared with the control groups. Exercise in
groups (exercise period ranging from 8 weeks to 12
month) lowered HbA1c approximately 0.6 percentage
points [14,15].
Dietary advice is an accepted cornerstone of treatment for
T2DM, but no quality data on the efficacy of diet interven-
tion per se on glycaemic control, reduction in body
weight, development of diabetic complications or quality
of life exists for the treatment of T2DM [16].
It is still an open question whether group-based or indi-
vidual lifestyle intervention programmes gives the best
glycaemic control, whether exercise interventions have a
long term effect and finally whether lifestyle changes can
improve long term results of T2DM treatment.
A new health care centre is established at Oesterbro in
eastern Copenhagen as a result of a local collaboration
project between the City of Copenhagen, Bispebjerg Uni-
versity Hospital and general practitioners [17]. The health
care centre is planned to be responsible for lifestyle reha-
bilitation of patients with one or more of four selected
chronic conditions – type 2 diabetes, chronic obstructive
pulmonary disease, chronic heart failure and older
patients with balance problems. A new rehabilitation pro-
gramme combines empowerment-based education, exer-
cise training and dietary advice on a group-based level as
one multi-disciplinary intervention.
The aim of the current study is to compare the metabolic,
physiological and psychological effects of this new group-
based multi-disciplinary lifestyle rehabilitation pro-
gramme for T2DM patients in a primary care setting with
an individual counselling programme in a diabetes outpa-
tient clinic. We hypothesize that patients participating in
the group-based rehabilitation programme including
supervised exercise will improve their glycaemic control,
self-rated diabetes symptoms and quality of life signifi-
cantly more in the short and long term than patients
receiving conventional individual advice on changes in
lifestyle.
Methods/design
Patient recruitment and randomization
We plan to recruit patients through advertisements in
local newspapers, pharmacies and from the outpatient
clinic at Bispebjerg University Hospital, and by letters and
e-mails to general practitioners inviting them to refer
patients to the study (Figure 1). Key inclusion and exclu-
sion criteria are shown in Figure 2. Diagnosis of T2DM is
defined according to the criteria of WHO [18]. Patients
willing to participate will be screened after written
informed consent is obtained, and those fulfilling the
inclusion criteria will be randomised within three weeks,
stratified by gender and age (18–54 years and ≥ 55 years).
A person not participating in the study creates a randomi-
zation list, and the randomization is done at the baseline
visit using consecutively numbered sealed envelopes.
Patients will be randomised to a group-based rehabilita-
tion programme (intervention group) at the Health Care
Centre Oesterbro or to an individual counselling pro-
gramme (control group) in the Diabetes Outpatient
Clinic, Bispebjerg University Hospital.
Intervention group
Lifestyle rehabilitation at Health Care Centre Oesterbro
consists of a multi-disciplinary intervention including
three programmes (Figure 3).
The education programme consists of one weekly group
session of 90 minutes for 6 weeks, limited to 8 patients
per group. A nurse, a physiotherapist, a dietician and a
podiatrist run the sessions. The education programme is
originally developed at the diabetes outpatient clinic, Bis-
pebjerg University Hospital, and focuses on achievement
of self-selected goals, psychosocial adaptation, enhanced
control and problem solving strategies [19]. The pro-
gramme is modified and adjusted to a multi-disciplinary
education team, and the contents of the sessions include
information on the pathophysiology of diabetes; the role
inheritance and environment; education in self blood-
glucose monitoring; the importance of physical activity,
healthy diet, weight loss, medication, and smoking cessa-
tion; the late complications of T2DM; hypertension and
cardiovascular disease. The podiatrist advises patients
about foot care and examines the patients' feet. The
empowerment approach to diabetes education involves
patient collaboration and seeks to increase the patients'
knowledge and self-awareness, which enables them to
take charge of their own diabetes self-management
[20].The diet instruction programme consists of two 3-
hours group-based cooking courses and 1 session in aBMC Public Health 2009, 9:166 http://www.biomedcentral.com/1471-2458/9/166
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local supermarket [21]. Patients' spouses are encouraged
to join the cooking courses.
The physical exercise programme is supervised and is 90
minutes in duration and sessions take place twice a week
for 12 weeks. The sessions are group-based, but a physio-
therapist tailors an individual exercise programme for
each patient including both aerobic and resistance exer-
cise [22]. After initial measurement of blood-glucose lev-
els, the patients start the warm-up exercise for 20 minutes.
This is followed by basic exercise training for 15 minutes,
followed by aerobic exercise on a bicycle ergometer for 12
minutes, resistance training (seated leg press, chest press,
pull down and leg extension) for 25 minutes, stretch for
10 minutes, followed by a final blood-glucose measure-
ment. The patients are advised to perform 30 minutes of
physical activity on at least three additional days per week
according to international guidelines [23]. In addition
patients are offered an optional smoking cessation
course if needed.
Before patients enter the programme they participate in an
individual motivational interview with a nurse or a phys-
iotherapist. The personnel are educated and continuously
supervised in the use of the motivational interviewing
technique by a specialized psychologist [24]. The patients
set personal goals, and these goals are evaluated after the
intervention programme at a final consultation and 1 and
3 months later by telephone follow-up contacts.
Flow-chart of events in the study Figure 1
Flow-chart of events in the study. From recruiting patients through randomization and follow-up.
Health 
Care 
Centre 
Advertis- 
ment 
Inclusion: 
HbA1c  
Follow-up 
Recruiment Screening  Baseline  6 month  12 month   24 month 
Out-
patient 
clinic 
Randomization
6.8-10% 
 
Outpatient 
clinic 
General 
practitioner 
Key inclusion and exclusion criteria Figure 2
Key inclusion and exclusion criteria.
Key inclusion criteria 
 
Known or newly diagnosed type 2 diabetes 
 
Men and women  
 
18 years of age or older 
 
Glycated haemoglobin 6.8–10.0% (both incl.) 
 
With or without one or more cardiovascular 
or neurological complications 
 
Key exclusion criteria 
 
Glycated haemoglobin above 10.0% 
 
Prior lifestyle intervention during the last year  
 
Planned to start treatment with insulin during 
the intervention period 
 
Severe heart, liver, or kidney disease or 
incurable cancer BMC Public Health 2009, 9:166 http://www.biomedcentral.com/1471-2458/9/166
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The group-based rehabilitation programme outline Figure 3
The group-based rehabilitation programme outline.
First visit  Group-based rehabilitation 
programme  
Final visit 
  
Education of   Individual 
motivational 
interviewing 
Individual follow-up 
meeting  self-management  
1.5 hours in 6 weeks   
    
Supervised exercise  Planning of the 
programme 
Evaluation of the 
programme  2 x 1.5 hours in 12 weeks 
    
Diet instruction  Evaluate personal 
goals 
Set personal goals 
2 x 3 hours cooking 
1 x 2 hours shopping advice   
  Future plans  Smoking cessation course  
(not mandatory) 
Individual outpatient counselling programme outline Figure 4
Individual outpatient counselling programme outline.
Education Diet-instruction 
Smoking cessation course (not mandatory) 
Content: 
1 session of 45 minutes 
 
 
Individual consultation 
Content: 
4 sessions of 1 hour 
 
 
Individual consultations 
Content: 
1 session of 1 hour 
2 sessions of 30 minutes 
 
Individual consultations 
Foot-care BMC Public Health 2009, 9:166 http://www.biomedcentral.com/1471-2458/9/166
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The teams from the health care centre and from the diabe-
tes outpatient clinic meet on a regular basis to share
knowledge and to ensure a common understanding of
care and agreement on the components of the pro-
grammes in the two organizations.
Control group
On the basis of the same empowerment approach the life-
style intervention at the Diabetes Out-patient clinic at Bis-
pebjerg Hospital includes four monthly 1-hour sessions
of individual counselling with a diabetes nurse specialist
[19,20] (Figure 4). The nurse is educated in the use of the
motivational interviewing technique and has a bachelor
degree in education. Using storytelling patients are given
information about diabetes in general, medication, risk
factors and late complications of T2DM. They receive
guidance in self-monitoring of blood-glucoses and on
how to increase their level of physical activity.
The programme also includes three individual counsel-
ling sessions with a dietician, who is also educated in the
use of the motivational interviewing technique[24]. The
patients' set personal goals and the dietician develops in
cooperation with the patient, a diet-schedule based on
biochemical, anthropometrical and medical records
including patients' motivation and attitudes. The sched-
ule and goals are evaluated at two 30-minute follow-up
visits.
The patients receive 45 minutes guidance and instructions
about foot-care from a podiatrist. Finally patients are
offered an optional smoking cessation course if required.
Pharmacological treatment
Both intervention programmes are non-pharmacological.
The endocrinologist or the general practitioner treating
and monitoring the patients prior to the study continue as
the patients' physician (disease manager) during and after
the intervention. Recent guidelines on pharmacological
treatment are followed [25]. The study does not include
changes in principles for the pharmacological treatment.
Patients are asked to report any alternation in their medi-
cation and these will be quantified by the study investiga-
tor and used in the analyses as a covariate.
Outcome measures and data collection
The primary outcome measure is glycosylated haemo-
globin (HbA1c). Secondary outcome measures are self-
rated quality of life and diabetes symptoms. Explanatory
outcome measures include blood pressure, lipid profile,
body weight, waist circumference, insulin resistance and
beta-cell function estimates, and physical fitness. All out-
come measures are collected at baseline and at follow-up
visits after 6, 12 and 24 months.
At every visit, biochemical, anthropometrical, physiologi-
cal and physical values are obtained. The same investiga-
tor measures the anthropometrical and the physiological
outcomes throughout the study. Physiotherapists at the
health care centre and at the outpatient clinic complete
the physical tests. The patients fill in two self-adminis-
tered questionnaires on quality of life and diabetes related
symptoms at each visit.
Anthropometrical measurements
Weight (kg) is measured without shoes in indoor clothing
and the same equipment will be used throughout the
study. Height (cm) without shoes is only measured at
baseline.
Waist circumference (cm) is measured at a level midway
between the lower rib margin and iliac crest with the sub-
jects standing without clothes on and with relaxed breath-
ing.
Physiological measurements
Electrocardiogram (ECG) is recorded at baseline. Blood
pressure is measured on both arms are done using an
aneroid manometer with the patient in a sitting position
after 10–15 minutes of relaxed conversation. The mean of
3 consecutive measurements is used for each arm.
Patients' target blood pressures are at the recommended
goal of 130/80 mmHg defined according to the European
guidelines [26].
Biothesiometry of the pulp on the first toe on both feet's
is used for quantitative assessment of peripheral neuropa-
thy. The patients will be tested by increasing the ampli-
tude from zero and then the patients will indicate when
they feel the vibration. The cut-off point for ulcer risk is >
25 volts [27].
Biochemical measurements
Blood and urine samples are taken in the morning after an
overnight fast. Plasma glucose, lipids, C Reactive Protein,
creatinine and urine albumin/creatinine ratio are ana-
lysed at the Department of Clinical Biochemistry, Bispeb-
jerg University Hospital. Haemoglobin A1c is measured
on venous whole blood samples in K2-EDTA tubes at the
Department of Clinical Biochemistry, Steno Diabetes
Centre [28]. Blood samples for serum C-peptide, insulin
and proinsulin are centrifuged for 10 min at 3000 rpm, at
20°C immediately after sampling, and serum is isolated
and frozen before analysis at the Steno Diabetes Centre.
Blood samples for later analyses will be centrifuged within
60 minutes of sampling and stored frozen at -20°C. The
target for haemoglobin A1c is below 6.5% according to
international guidelines [27].BMC Public Health 2009, 9:166 http://www.biomedcentral.com/1471-2458/9/166
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The Homeostasis Model Assessment (HOMA) is used to
estimate insulin resistance and beta-cell function [29].
HOMA-IR is computed as follows: fasting insulin (μU/ml)
× fasting glucose (mmol/L)/22.5. HOMA-B is calculated
using the following formula: 20 × fasting insulin (μU/
ml)/fasting glucose (mmol/L) – 3.5.
Microalbuminuria is defined as a urine Albumin:Creati-
nine Ratio (ACR) ≥ 2.5 – 25 mg/mmol in men and ≥ 3.5
– 25 mg/mmol in women [30]. Treatment targets for
blood lipids are values of fasting total cholesterol below
4.5 mmol/L and fasting LDL cholesterol below 2.5 mmol/
L [31].
Physical measurements
Patients above 60 years of age perform a 6 minutes walk
test in an indoor unobstructed corridor. They are
instructed by a physical therapist to walk the 30 meter
from one end to the other at their own pace, as many
times as possible, in the permitted time. After 6 minutes,
the total distance walked (in meter) is measured. The 6
minute walk test is a useful measure of functional capac-
ity, targeted at older people and people with moderate-to-
severe physical impairment and has well known reference
equations [32,33].
For patients below 60 years of age physical fitness is meas-
ured by using a submaximal cycle ergometer aerobic fit-
ness test (Astrand-Rhyming Cycle Ergometer Test).
Patients cycle on an ergometer at a constant workload for
6 minutes. Heart rate is measured every minute, and based
on the steady state heart rate, VO2 max (correlation to VO2
max approximately 0.85–0.9) is determined from a nom-
ogram [34,35].
All participants perform a strength test that involves the
determination of the maximum weight that can be lifted
5 repetitive times by arms and legs while maintaining
proper form (5RM test) [36]. Self reported daily physical
activity (average hours per week in the last 6 months) is
divided into: 1) Transportation exercise: walking and
bicycling and 2) Training exercise: jogging, training in a
fitness centre, swimming, bicycling, etc[36].
Quality of life questionnaires
Short Form Health Survey (SF-36) is a multi-purpose,
short-form health survey with 36 questions. It yields an 8-
scale profile of functional health and well-being scores as
well as psychometrically-based physical and mental
health summary measures and a preference-based health
utility index. The SF-36 has proven to be useful in surveys
of general and specific populations, comparing the rela-
tive burden of diseases, and has been used to differentiate
the health benefits produced by a wide range of different
treatments [37]. A higher score on SF-36 indicates an
improvement in Quality of Life.
Diabetes Symptom Checklist – Revised (DSC-R) is a self-
report questionnaire of 34 questions grouped into 8
symptom subscales measuring the occurrence and per-
ceived burden of diabetes-related symptoms [38]. It has
been described to be valid, reliable and responsive to
change and to be the only scale that appears to evaluate
physical functioning in T2DM patients in a broad, com-
prehensive manner [39]. A lower score on DSC-R indi-
cates an improvement in Quality of Life.
Sample size considerations and statistical methods
The size of the study population is based on the primary
outcome measure HbA1c and is estimated on the basis of
the results of two meta-analyses relating to education and
exercises in T2DM patients [8,14]. According to power cal-
culation, an absolute difference of 0.7% in HbA1c
between the groups (power 0.9, significance level 0.05)
may be detected with 80 patients in each group. This cal-
culation is based on a standard deviation of the HbA1c-
value of 1.3 from larger population studies [40].
Neither patients nor study personnel are blinded to treat-
ment assignment. The study statistician carrying out the
data analysis on the primary and secondary outcomes will
be blinded and will not have any contact with the
patients.
Descriptive statistics (means ± SD, or median and inter-
quartile ranges, as appropriate) will be used to describe
the study sample with regards to baseline characteristics.
The analysis will be performed according to the intention-
to-treat principles using the statistical software SAS 9.1.
Comparisons of primary and secondary outcomes
between the two groups will be analyzed by values after
the intervention at the 6 months follow-up visit, and 12
and 24 months after baseline, using appropriate paramet-
ric tests for variables fulfilling the normal distribution cri-
teria or appropriate non-parametric tests for variables not
fulfilling the normal distribution criteria. Sensitivity anal-
yses will be carried out with adjustment for possible con-
founders. When relevant the change in outcomes from
baseline to 6, 12 and 24 months follow-up will be
assessed. The proportion of patients reaching the recom-
mended goals for glycated haemoglobin, blood pressure
and lipids will be compared in a sub-analysis. Statistical
significance is set at P < 0.05.
Ethics
The study will be conducted according to the principles of
the Helsinki declaration. The Danish National Committee
on Biomedical Research Ethics and the Danish Data Pro-
tection Agency have approved the study protocol.BMC Public Health 2009, 9:166 http://www.biomedcentral.com/1471-2458/9/166
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Discussion
This prospective, controlled and randomized open label
study tests the hypothesis that a new multi-disciplinary
group-based lifestyle intervention programme for T2DM
patients in a primary health care setting results in better
short- and long-term glycaemic outcomes than the tradi-
tional best practice for individual lifestyle counselling in a
diabetes outpatient clinic setting. The major difference
between the two interventions is that the new rehabilita-
tion programme includes a supervised exercise pro-
gramme, whereas the control group receives advice
regarding physical activity. The content and the principles
of empowering patients are the same in the two interven-
tions, but the education programme in the health care
centre is group-based.
The evidence of the beneficial effects of exercise on diabe-
tes symptoms, physical fitness and quality of life in T2DM
is strong [41], and previous group-based non-pharmaco-
logical lifestyle studies show improvement in glycaemic
control and weight loss compared to individual counsel-
ling [9]. Most lifestyle intervention studies have been
focused mainly on education, including advice on physi-
cal activity and diet, or on exercise training and/or diet.
Only a few randomized controlled trials have investigated
interventions incorporating several elements of non-phar-
macological treatment of T2DM including patient educa-
tion, supervised exercise and dietary advice on a group-
based level [42-45]. However, the number of patients, fol-
low-up time and effects on glycaemic control were very
heterogeneous in these studies. It is very important in
T2DM management programmes to find ways to increase
the impact of non-pharmacological treatment in T2DM
patients. Our study may add further evidence to this.
The lifestyle rehabilitation programme is multi-discipli-
nary including group-based education, dietary advice and
exercise, and it is not possible to extract the individual
effects of each component. The interventions are non-
pharmacological, but the patients are urged to continue
their medication throughout the study since the clinical
effects of a multi-pharmacological treatment on late dia-
betic complications are highly significant [46]. Decisions
on changes in medication are left to the discretion of the
patients' physicians, who are not part of this study.
Disease management programmes tailored to the Danish
health care system are currently developed for T2DM and
other chronic conditions. Provision of rehabilitation pro-
grammes for T2DM patients in a community-based set-
ting, and health care centres, are a possible future part of
the organization of prevention and chronic care in pri-
mary care, and it is therefore essential to provide evidence
for the patient-related effects. The evidence generated
from The Copenhagen Type 2 Diabetes Rehabilitation
Project may be helpful in the decision making of provid-
ers to choose the most suitable lifestyle programme for
their T2DM patients.
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